Scholarly article on topic 'Locomotor training through a novel robotic platform for gait rehabilitation in pediatric population: short report'

Locomotor training through a novel robotic platform for gait rehabilitation in pediatric population: short report Academic research paper on "Medical engineering"

Share paper
OECD Field of science

Academic research paper on topic "Locomotor training through a novel robotic platform for gait rehabilitation in pediatric population: short report"

Bayón et al. Journal of NeuroEngineering and Rehabilitation (2016) 13:98 DOI 10.1186/s12984-016-0206-x

Journal of NeuroEngineering and Rehabilitation


Locomotor training through a novel robotic platform for gait rehabilitation in pediatric population: short report

C. Bayon1, S. Lerma2, O. Ramirez1, J.I. Serrano1, M.D. Del Castillo1, R. Raya1, J.M. Belda-Lois3,1. Martinez2 and E. Rocon1,4*


Background: Cerebral Palsy (CP) is a disorder of posture and movement due to a defect in the immature brain. The use of robotic devices as alternative treatment to improve the gait function in patients with CP has increased. Nevertheless, current gait trainers are focused on controlling complete joint trajectories, avoiding postural control and the adaptation of the therapy to a specific patient. This paper presents the applicability of a new robotic platform called CPWalker in children with spastic diplegia.

Findings: CPWalker consists of a smart walker with body weight and autonomous locomotion support and an exoskeleton for joint motion support. Likewise, CPWalker enables strategies to improve postural control during walking. The integrated robotic platform provides means for testing novel gait rehabilitation therapies in subjects with CP and similar motor disorders. Patient-tailored therapies were programmed in the device for its evaluation in three children with spastic diplegia for 5 weeks.

After ten sessions of personalized training with CPWalker, the children improved the mean velocity (51.94 ±41. 97 %), cadence (29.19 ±33.36 %) and step length (26.49 ± 19.58 %) in each leg. Post-3D gait assessments provided kinematic outcomes closer to normal values than Pre-3D assessments.

Conclusions: The results show the potential of the novel robotic platform to serve as a rehabilitation tool. The autonomous locomotion and impedance control enhanced the children's participation during therapies. Moreover, participants' postural control was substantially improved, which indicates the usefulness of the approach based on promoting the patient's trunk control while the locomotion therapy is executed. Although results are promising, further studies with bigger sample size are required.

Keywords: Cerebral palsy, Rehabilitation robotic, Gait, Posture, Exoskeleton device, Spastic diplegia, Case report


One of the most important consequences of Cerebral Palsy (CP) in children is mobility impairment, characterized by reduced speed and endurance or shortened step length during gait [1]. In last decades, robot-based therapy has complemented conventional strategies in CP gait rehabilitation [2, 3]. Several rehabilitation devices have been recently proposed with this aim [4, 5]. The majority

* Correspondence:

1Neuraland Cognitive Engineering group, Centro de Automática y Robótica, Consejo Superior de Investigaciones Científicas, Ctra Campo Realkm 0.2, Arganda delRey, Madrid 28500, Spain

4Postgraduate Program, Universidade Federaldo Espirito Santo, Vitória, Brazil Full list of author information is available at the end of the article

(3 BioMed Central

of these platforms (e.g. Lokomat [4], GT-1 [5]) includes the approach of Partial Body-Weight Support (PBWS) and guided and repetitive movement. However, therapies carried out with common available devices are similar for all subjects, despite the cognitive and physical differences among them make important to tailor the therapy to the specific patient's needs. Taking into account that maintaining a proper posture during walking is a relevant aspect in the case of children with CP [6, 7], new strategies are needed to improve postural control while over-ground movement is allowed.

In order to address these limitations, a novel robotic platform (CPWalker [8]) has been designed. It can

© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.C International License (, which permits unrestricted use, distribution, anc reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

implement new types of therapies in children with CP. The shift that CPWalker introduces on the treatments is supported by three main pillars: a) the option of free and over-ground movement (not restricted to treadmill) in rehabilitation environment; b) the improvement of postural control of head and trunk using a biofeedback strategy; and c) the use of "Assist As Needed" (AAN) strategies in specific and selected subtasks of walking.



Three pediatric patients with spastic diplegia (one female), two suffering from spastic CP and one from Hereditary Spastic Paraparesis (HSP), were recruited to participate in this study (Table 1). The inclusion criteria for the patient's recruitment was: a) capable of understanding the proposed exercises; b) aged 11 to 18 years; c) maximum weight 75 kg; d) children with no deformations that could prevent the use of the exoskeleton; e) Gross Motor Function Classification System (GMFCS) levels I to III; f) able to signal pain or discomfort. The exclusion criteria of this study was defined as: a) unhealed skin lesions in the lower limbs; b) aggressive or self-harming behaviors; c) severe cognitive impairment.

The clinical trial was carried out at "Hospital Infantil Universitario Niño Jesús". The Local Ethical Committee of this hospital gave approval to the study, and warranted its accordance with the Declaration of Helsinki. All patients and families were informed beforehand, and provided consent through parents to participate.

Experimental apparatus

The platform used in this study to help the users to recover the gait function is the robotic trainer CPWalker (Fig. 1) described in detail in [8]. CPWalker incorporates actuators in both the walker and the exoskeleton, to constitute an active rehabilitation robotic platform. The included systems, showed in Fig. 1, are: a) a drive system to provide the translation movement required for an am-bulation treatment in real rehabilitation environments instead of treadmill training; b) PBWS system to unload the child from the ground with the therapeutic benefits of improving balance and other characteristics such as symmetry or stride length [9, 10]; c) a system for the control of hip height, to adapt the robotic platform to different anthropometric measures; and d) a six Degrees Of Freedom (6-DOF) adjustable exoskeleton system for

Table 1 Description of the patients

Fig. 1 Finalview of the CPWalker Platform. a Drive system which provides free movement of the platform; b PBWS system that allow the possibility of choosing the discharge of weight that support the child's lower limbs; c System for the controlof hip height in order to adapt the platform to different anthropometric measures; d Exoskeletor system with actuated joints in hip and knee

Patient Disease GMFCS Age Weight [kg]

Patient 1 Spastic diplegia-CP III 14 32

Patient 2 Spastic diplegia-CP 12 40

Patient 3 Spastic diplegia-HSP - 13 43

providing guided movements in sagittal plane. A video showing the experimentations with patients is available in the Additional file 1.


The training with CPWalker was performed for 5 weeks, 2 days per week (10 training sessions), with the exercise time for each day set at 60 min, including 10 min of setup time. The exercises consisted of walking with the robotic device through routes in flat and straight lines into the hospital facilities.

The therapies were individually adapted for each patient aiming at enhancing the most affected region in each case (according to the results of gait assessments done before to start with robot-based therapies). Specifically, the treatment defined for Patient 1 and Patient 3 attempted to improve the postural control of the trunk during walking. As a result, a stiffer impedance control of the lower limbs joints was set to assist the users' movement while they were more focused on posture control using a biofeedback strategy. On the other hand, with Patient 2 the main purpose was to improve the range of motion (ROM) of the hip joint, primarily the extension movement. In order to address this rehabilitation, a less stiff impedance control of this joint was adjusted to intensify Patient 2's collaboration in reaching the maximum extension of the hip. Given that

Fig. 2 Evolution of therapy parameters in Patient 1. a Percent of the range of motion of a healthy user programmed in the robot. b Percent of the subject body weight supported by the platform. These parameters were adjusted during the treatment in order to tailor the therapy to each patient

this child had rigid Ankle-Foot Orthoses (AFO), the ankle joints were fixed to 90°. With no actuation on ankles, the propulsion on the ground was not high enough, so we imposed position control to knee joints in order to achieve a proper knee flexion. For this patient the biofeedback strategy for postural control was set with a bigger tolerance, which enabled the patient to be more focused on improving the hip movement.

With the aim of accommodating the patients to the robotic platform and following therapists' recommendations, all of them were completely suspended during the first sessions (PBWS of 100 %), and the PBWS was gradually decreased along the course of 5 weeks of the study (Fig. 2). This approach allowed the subjects to gradually get used to support their weight on their own legs. In the same way, the percent of ROM applied for each joint respect to a normal gait pattern (Fig. 2) and the gait speed were updated during the therapy with the purpose of increasing the difficulty of the exercise.

According to the pre-measured capabilities for each child and following recommendations from our clinical partners, the parameters were selected before to start the robotic therapy (Table 2).

The designed therapies were based on two key features: an interface to correct the user's posture during robot-assisted walking and a selective impedance control to achieve the tailored therapy related to the patient's needs.

Table 2 Selected parameters according to patients' capabilities

% ROM % PBWS Gait speed (m/s)

Beginning Desired End Beginning Desired End Beginning Desired End

Patient 1 80 100 100 50 0.172 0.210

Patient 2 85 90 100 60 0.159 0.210

Patient 3 73 88 100 65 0.133 0.188

Fig. 3 IMUs based interface to give biofeedback of postural control in head and trunk. The graphics show IMUs data collected in realtime for head and trunk in three planes (blue lines), and these are compared with hip ROM (red lines). The red squares represent postures out of the limit values (acoustic feedback playing)

Table 3 Comparison between Pre and Post studies

Pre 3D analysis Post 3D analysis Normality

Patient Parameter Right side Left side Right side Left side

Patient 1 Mean velocity (m/s) 0.40 ± 0 0.49 ± 0 1.20 ± .20

Cadence (step/min) 73.80 ±6.00 75.80 ± 7.97 129.60 ±8.40

Step length (m) 0.30 ±.01 0.24 ± .04 0.33 ± .02 0.27 ±.01 0.58 ±.06

Trunk rotation Percentage range (max-min) 286.29 % 248.71 % 204.84 % 233.87 % 100 %

Maximum peak 14.83° 0° 4° 10° 4.80°

Minimum peak -2.92° -15.42° -8.70° -4.50° -2.40°

Patient 2 Mean velocity (m/s) 0.60 ± .10 0.80 ± 0 1.20 ± .20

Cadence (step/min) 102.20 ± 12.65 120.8 ±9.38 129.60 ±8.40

Step length (m) 0.31 ± .03 0.24 ± .05 0.40 ±.01 0.38 ± .02 0.58 ±.06

Hip ROM flex-ext Percentage range (max-min) 70.63 % 85.82 % 95.19 % 96.20 % 100 %

Maximum peak (flexion) 46.40° 48.40° 41.90° 39.50° 37.10°

Minimum peak (extension) 18.50° 14.50° 4.30° 1.50° -2.40°

Patient 3 Mean velocity (m/s) 0.20 ± 0 0.40 ± 0 1.20 ± .20

Cadence (step/min) 45 ± 3.70 75 ± .60 129.60 ±8.40

Step length (m) 0.23 ± .05 0.30 ± .05 0.32 ± .02 0.33 ± .04 0.58 ±.06

Trunk rotation Percentage range (max-min) 343.55 % 350.48 % 224.52 % 234.35 % 100 %

Maximum peak 20° 2.60° 8.25° 6.28° 4.80°

Minimum peak -1.30° -19.13° -5.67° -8.25° -2.40°

Temporal, spatial parameters and kinematic data related with the selected improvements for each patient (correspondence with Fig. 4)

Postural control therapy

The biofeedback strategy for postural control was based on inertial measurement unit (IMU) sensors (Fig. 3). Two IMU sensors, placed on the user's chest and head, measured the orientation of the trunk and head respectively. The procedure based on this approach consisted in giving acoustic feedback to the users when their trunk or head were not in a proper position, which was defined by the clinicians (see clinical interface on the left of Fig. 3). The measures provided by this biofeedback strategy were important during the execution of the therapy: while the exoskeleton corrected the patients' gait, the postural control strategy motivated them to maintain a proper posture during ambulation [6, 7, 11]. Figure 3-right shows an example of recording data in real time from IMUs-based system, where the measured angles for head and trunk (blue lines) in three spatial planes are compared to the ROM of the left hip during walking (red lines). Red squares in Fig. 3-left represent posture out of the permitted range and where acoustic feedback was given.

Assist as needed therapy

The AAN philosophy was included into the control via a selective impedance control strategy [12], which was implemented in specific and selected subtasks during walking therapy. This approach increased the patient's active participation during the exercise performance.

The method considers the interaction torque between the user and the exoskeleton, allowing a variable deviation from the predefined reference trajectories. As a result, CPWalker attempts to prevent undesired efforts on lower limbs and to take advantage of patient's residual movements.


Children's 3D gait assessments without the aid of CPWalker were conducted before and after the robot-based therapy. This analysis provided kinematic data and temporal-spatial parameters that were used to evaluate the progression of the therapy.

After 5 weeks of robot-based training with CPWalker system the three children improved the mean velocity, cadence and step length with each leg (Table 3). Additionally, taking into account the kinematic analysis, the three subjects progressed in their gait as Fig. 4 and Table 3 shown. Post-3D studies revealed that the trajectories for right and left lower limbs are closer to the normal values when compared to pre-3D studies. All children succeeded the goals proposed on Table 2.

As the therapies were individually tailored for each patient, the results have to be understood as separate case studies.

Fig. 4 Outcomes from kinematic analysis in Patient 1, 2 and 3 without the robotic aid. The graphics show the improvements for each patient depend on the focus of each therapy. Green lines are referred to right side and Red lines to left side. Dashed lines correspond to 3D studies done before the robotic treatment and Continuous lines to 3D studies done after 5 weeks of robot-based therapy

Discussion and conclusion

This contribution has presented the importance of considering novel robot-based strategies for gait rehabilitation and its previous results from a validation using the CPWalker device with pediatric population. The strength of the robotic platform used in this study is the capability of AAN gait training with displacement in real environment while the apparatus provides feedback in order to correct the child's posture. These functions enabled the definition of tailored therapies for each patient.

Although outcomes are quite promising, we acknowledge that the population size of this pilot trial, the reduced time of intervention (only 10 sessions) and the

short-term follow up are the main limitations of this research. Future work will be focused on performing a proper clinical evaluation with an increased number of patients. These studies are necessary to determine if gains will have long-term and lasting impact for children with CP and other similar disorders.

Additionally, we are currently evaluating the effectiveness of a non-invasive way for promoting a more active participation of central nervous system into the rehabilitation strategy in order to allow the implementation of a "Top-Down" approach [13].

Additional file

Additional file 1: Video illustrating the rehabilitation process based on the CPWalker robotic platform. (MP4 17260 kb)


AAN: Assist as needed; AFO: Ankle-foot orthoses; CP: Cerebral palsy; DOF: Degrees of freedom; GMFCS: Gross motor function classification system; HSP: Hereditary spastic paraparesis; IMUs: Inertial measurement unit; PBWS: Partial body weight support; ROM: Range of motion


Authors would like to thank Made for Movement company for providing and supporting us in the mechanical design of a NF-Walker device. We also greatly appreciate the efforts and contributions from all the testing subjects and their families.


The work presented in this paper has been carried out with the financial support from the Ministerio de Economía y Competitividad of Spain, under Contract DPI2012-39133-C03-01.

Availability of data and materials

The data supporting the conclusions of this article are included within the article and its additional files.

Authors' contributions

CB developed the control algorithm of the robotic device, designed the control architecture, and drafted the manuscript. SLL aided in the development of the protocol and patient's recruitment and he also collaborated in the review and critique of the manuscript. OR was involved in the development of the hardware of the system. JIS was responsible for the development of the interface with CPWalker. MDC also was involved in the development of the interface with CPWalker. RR collaborated in the review and critique of the manuscript. JMB was responsible for the development of the mechanical design of the robotic platform and he also collaborated in the review and critique of the manuscript. IMC aided in the development of the protocol and patient's recruitment. ER collaborated in all facets of the project. ALL AUTHORS read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests. Consent for publication

Consent for publication has been given by parents or legal guardians of involved children.

Ethics approval and consent to participate

The Local Ethical Committee of the "Hospital Infantil Universitario Niño Jesús" gave approval to the study, and warranted its accordance with the Declaration of Helsinki. The study was carried out with the number R-0032/12 from Local Ethical Committee of the Hospital. All patients and families were informed beforehand, and provided consent through parents to participate.

Author details

1Neural and Cognitive Engineering group, Centro de Automática y Robótica, Consejo Superior de Investigaciones Científicas, Ctra Campo Real km 0.2, Arganda del Rey, Madrid 28500, Spain. 2Hospital Infantil Universitario Niño Jesús, Madrid, Spain. 3Instituto de Biomecánica de Valencia, Valencia, Spain. 4Postgraduate Program, Universidade Federal do Espírito Santo, Vitória, Brazil.

Received: 17 March 2016 Accepted: 25 October 2016 Published online: 14 November 2016


1. Pirpiris M, Wilkinson AJ, Rodda J, Nguyen TC, Baker RJ, Nattrass GR, et al. Walking speed in children and young adults with neuromuscular disease: comparison between two assessment methods. J Pediatr Orthop. 2003;23:302-7.

2. Fasoli SE, Ladenheim B, Mast J, Krebs HI. New horizons for robot-assisted therapy in pediatrics. Am J Phys Med Rehabil. 2012;91:S280-9. doi:10.1097/ PHM.0b013e31826bcff4.

3. Bayón C, Raya R, Lara SL, Ramírez O, Serrano J, Rocon E. Robotic Therapies for Children with Cerebral Palsy: A Systematic Review. Transl Biomed. 2016;7:1 -10. doi:10.21767/2172-0479.100044.

4. Borggraefe I, Kiwull L, Schaefer JS, Koerte I, Blaschek A, Meyer-Heim A, et al. Sustainability of motor performance after robotic-assisted treadmill therapy in children: an open, non-randomized baseline-treatment study. Eur J Phys Rehabil Med. 2010;46:125-31.

5. Smania N, Bonetti P, Gandolfi M, Cosentino A, Waldner A, Hesse S,

et al. Improved gait after repetitive locomotor training in children with cerebral palsy. Am J Phys Med Rehabil. 2011;90:137-49. doi:10.1097/ PHM.0b013e318201741e.

6. Dewar R, Love S, Johnston LM. Exercise interventions improve postural control in children with cerebral palsy: a systematic review. Dev Med Child Neurol. 2014;57:504-20. doi:10.1111/dmcn.12660.

7. Abd El-Kafy E, El-Basatini H. Effect of postural balance training on gait parameters in children with cerebral palsy. Am J Phys Med Rehabil. 2014;93:938-47.

8. Bayón C, Ramírez O, del Castillo MD, Serrano JI, Raya R, Belda-Lois JM, et al. CPWalker: Robotic Platform for Gait Rehabilitation in Patients with Cerebral Palsy. IEEE Int. Conf. Robot. Autom., 2016. doi:10.1007/s13398-014-0173-7.2.

9. Willoughby K, Dodd K, Shields N. A systematic review of the effectiveness of treadmill training for children with cerebral palsy. Disabil Rehabil. 2009;31: 1971-80.

10. Damiano DL, DeJong SL. A systematic review of the effectiveness of treadmill training and body weight support in pediatric rehabilitation.

J Neurol Phys Ther. 2009;33:27-44. doi:10.1097/NPT.0b013e31819800e2.

11. Robert MT, Guberek R, Sveistrup H, Levin MF. Motor learning in children with hemiplegic cerebral palsy and the role of sensation in short-term motor training of goal-directed reaching. Dev Med Child Neurol. 2013;55:1121-8. doi:10.1111/dmcn.12219.

12. Hogan N. Impedance Control: An Approach to Manipulation: parts I, II and III. J Dyn Syst Meas Control. 1985;107:1-7.

13. Gallego JÁ, Ibanez J, Dideriksen JL, Serrano JI, Del Castillo MD, Farina D,

et al. A Multimodal Human-Robot Interface to Drive a Neuroprosthesis for Tremor Management. IEEE Trans Syst Man, Cybern Part C Applications Rev. 2012;42:1159-68. doi:10.1109/TSMCC.2012.2200101.

Submit your next manuscript to BioMed Central and we will help you at every step:

• We accept pre-submission inquiries

• Our selector tool helps you to find the most relevant journal

• We provide round the clock customer support

• Convenient online submission

• Thorough peer review

• Inclusion in PubMed and all major indexing services

• Maximum visibility for your research

Submit your manuscript at